Cargando…

Characteristics of Primary Bradyarrhythmia in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Analysis

Background: Secondary bradyarrhythmias in hypertrophic cardiomyopathy (HCM) have been extensively reported. The prevalence and characteristics of primary bradyarrhythmias in HCM have yet to be investigated. Methods: We retrospectively enrolled 101 consecutive patients with HCM who were referred to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hong-Da, Tang, Min, Zhang, Jing-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698031/ https://www.ncbi.nlm.nih.gov/pubmed/36354769 http://dx.doi.org/10.3390/jcdd9110370

Ejemplares similares

Future bradyarrhythmia in patients with hypertrophic cardiomyopathy
por: Nakasuka, Kosuke, et al.
Publicado: (2021)

Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
por: Zhang, Hong-Da, et al.
Publicado: (2021)

Bradyarrhythmias: First Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy?
por: Burghouwt, Danielle E, et al.
Publicado: (2015)

Takotsubo cardiomyopathy with severe bradyarrhythmia following epidural insertion
por: Gamble, David T, et al.
Publicado: (2016)

Commentary: Characteristics and Long-Term Ablation Outcomes of Supraventricular Arrhythmias in Hypertrophic Cardiomyopathy: A 10-Year, Single-Center Experience
por: Shen, Rui-Huan, et al.
Publicado: (2022)

Bradyarrhythmias in Cardio-Oncology
por: Fonseca, Marta, et al.
Publicado: (2021)

Traditional Chinese Medicine for Bradyarrhythmia: Evidence and Potential Mechanisms
por: Liu, Shuo, et al.
Publicado: (2018)

Different characteristics of heart failure due to pump failure and bradyarrhythmia
por: Iwataki, Mai, et al.
Publicado: (2014)

Ticagrelor-Induced Syncope/Bradyarrhythmia
por: Kotaru, VeeraPavan, et al.
Publicado: (2021)

Bradyarrhythmia in COVID-19 Patients
por: Hakami, Abdulrahman, et al.
Publicado: (2021)

Evaluation and Management of Asymptomatic Bradyarrhythmias
por: Çinier, Göksel, et al.
Publicado: (2021)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Cardiac lymphoma presenting as bradyarrhythmia
por: Sanders, Mason, et al.
Publicado: (2022)

Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy
por: Xiao, Yan, et al.
Publicado: (2015)

Tachyarrhythmias, bradyarrhythmias and acute coronary syndromes
por: Trappe, Hans-Joachim
Publicado: (2010)

Violent Hiccups: An Infrequent Cause of Bradyarrhythmias
por: Suh, William M., et al.
Publicado: (2009)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy in a Latin American Center: A Single Center Observational Study
por: López-Ponce de Leon, Juan David, et al.
Publicado: (2023)

The impact of hypertension on the prognosis of patients with hypertrophic cardiomyopathy: a single-center retrospective study
por: Wang, Ziqiong, et al.
Publicado: (2023)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

RISK FACTORS AND THE PROGNOSTIC SIGNIFICANCE OF COVID 19 INDUCED BRADYARRHYTHMIA: A SINGLE CENTER RETROSPECTIVE COHORT ANALYSIS.
por: Awadelkarim, Abdalaziz, et al.
Publicado: (2023)

Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy
por: Alashi, Alaa, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies
por: Vio, Riccardo, et al.
Publicado: (2021)

Differences in Characteristics and Outcomes Between Patients With Hypertrophic Cardiomyopathy From Asian and European Centers
por: Tjahjadi, Catherina, et al.
Publicado: (2022)

Bradyarrhythmias secondary to topical levobunolol hydrochloride solution
por: Lin, Lianjun, et al.
Publicado: (2014)

Phenytoin induced sinoatrial bradyarrhythmia in the perioperative period
por: Kakkar, Aanchal, et al.
Publicado: (2013)

Life-threatening bradyarrhythmia with oral phenytoin overdose
por: Srinivasan, Giridharan, et al.
Publicado: (2015)

Inherited bradyarrhythmia: A diverse genetic background
por: Ishikawa, Taisuke, et al.
Publicado: (2016)

Translational implications of bradyarrhythmia in hibernating brown bears
por: Gottlieb, Lisa A., et al.
Publicado: (2023)

Prognosis of patients with familial hypertrophic cardiomyopathy: A single-center cohort study with ten-year follow-up by propensity score matching analysis
por: He, Ye, et al.
Publicado: (2023)

Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2023)

ECG Abnormalities Preceding Structural Changes of Apical Hypertrophic Cardiomyopathy by up to 10 Years
por: McManus, Taylor, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Diagnosis of hypertrophic cardiomyopathy accompanied with primary aldosteronism—Case report
por: Tang, Kaiyu, et al.
Publicado: (2023)

Recent advances in hypertrophic cardiomyopathy
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2014)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Bradyarrhythmias in patients with COVID-19: A case series
por: Gupta, Mohit D., et al.
Publicado: (2020)

Cardioneuroablation for treating functional bradyarrhythmias. How much is enough?
por: Pachon-M, J.C., et al.
Publicado: (2021)

COVID‐19 induced bradyarrhythmia and relative bradycardia: An overview
por: Douedi, Steven, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_30btc88j9l02m86jt15iklrl7v